ADENOSINE

N/A

Manufactured by Dalim Tissen

3,219 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ADENOSINE

ADENOSINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Dalim Tissen. The most commonly reported adverse reactions for ADENOSINE include DRUG INEFFECTIVE, OFF LABEL USE, SUPRAVENTRICULAR TACHYCARDIA, HYPOTENSION, CARDIAC ARREST. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ADENOSINE.

Top Adverse Reactions

DRUG INEFFECTIVE327 reports
OFF LABEL USE98 reports
SUPRAVENTRICULAR TACHYCARDIA94 reports
HYPOTENSION86 reports
CARDIAC ARREST78 reports
DYSPNOEA74 reports
PAIN67 reports
ATRIAL FIBRILLATION64 reports
BRADYCARDIA63 reports
TACHYCARDIA61 reports
ANXIETY55 reports
DRUG INTERACTION53 reports
NAUSEA52 reports
VENTRICULAR TACHYCARDIA49 reports
DIZZINESS48 reports
PNEUMONIA43 reports
BRONCHOSPASM41 reports
PRODUCT USE IN UNAPPROVED INDICATION41 reports
FATIGUE39 reports
EMOTIONAL DISTRESS37 reports
HYPERTENSION36 reports
VENTRICULAR FIBRILLATION36 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION35 reports
ASTHENIA33 reports
CONDITION AGGRAVATED33 reports
MATERNAL EXPOSURE DURING PREGNANCY33 reports
RENAL FAILURE33 reports
TREATMENT FAILURE33 reports
FOETAL EXPOSURE DURING PREGNANCY32 reports
ANHEDONIA31 reports
HEADACHE29 reports
PLEURAL EFFUSION29 reports
TOXICITY TO VARIOUS AGENTS29 reports
ACUTE KIDNEY INJURY28 reports
CARDIOGENIC SHOCK28 reports
PULMONARY EMBOLISM28 reports
ARTERIOSPASM CORONARY27 reports
ATRIOVENTRICULAR BLOCK27 reports
VOMITING27 reports
CHEST PAIN26 reports
CARDIO RESPIRATORY ARREST25 reports
CHRONIC KIDNEY DISEASE25 reports
INJURY24 reports
ARRHYTHMIA23 reports
CIRCULATORY COLLAPSE23 reports
DIARRHOEA23 reports
EXPOSURE DURING PREGNANCY23 reports
HYPERSENSITIVITY23 reports
LIVER FUNCTION TEST ABNORMAL23 reports
MALAISE23 reports
MYOSITIS23 reports
OEDEMA PERIPHERAL23 reports
ALANINE AMINOTRANSFERASE INCREASED22 reports
PRURITUS22 reports
RENAL FAILURE ACUTE22 reports
HYPOXIA21 reports
LOSS OF CONSCIOUSNESS21 reports
METABOLIC ACIDOSIS21 reports
PERICARDIAL EFFUSION21 reports
PRODUCT USE ISSUE21 reports
PYREXIA21 reports
RESPIRATORY FAILURE21 reports
BLOOD PRESSURE INCREASED20 reports
COUGH20 reports
DEPRESSION20 reports
PALPITATIONS20 reports
PREMATURE BABY20 reports
RASH20 reports
ATRIOVENTRICULAR BLOCK COMPLETE19 reports
BLOOD CREATININE INCREASED19 reports
SEPSIS19 reports
ANAEMIA18 reports
ASPARTATE AMINOTRANSFERASE INCREASED18 reports
CARDIAC FAILURE18 reports
HAEMOGLOBIN DECREASED18 reports
HEART RATE INCREASED18 reports
ACUTE MYOCARDIAL INFARCTION17 reports
DECREASED APPETITE17 reports
HAEMODYNAMIC INSTABILITY17 reports
PAIN IN EXTREMITY17 reports
RESPIRATORY DISTRESS17 reports
UNEVALUABLE EVENT17 reports
OSTEOPOROSIS16 reports
OVERDOSE16 reports
RENAL IMPAIRMENT16 reports
SYNCOPE16 reports
THERAPY NON RESPONDER16 reports
THROMBOCYTOPENIA16 reports
VENTRICULAR EXTRASYSTOLES16 reports
DEATH15 reports
ECONOMIC PROBLEM15 reports
FALL15 reports
INFECTION15 reports
PULMONARY OEDEMA15 reports
RESPIRATORY ARREST15 reports
TOXIC EPIDERMAL NECROLYSIS15 reports
ABDOMINAL PAIN14 reports
BLOOD PRESSURE DECREASED14 reports
FLUID OVERLOAD14 reports
OSTEOPENIA14 reports

Report Outcomes

Out of 1,547 classified reports for ADENOSINE:

Serious 89.0%Non-Serious 11.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male693 (51.4%)
Female645 (47.9%)
Unknown9 (0.7%)

Reports by Age

Age 5644 reports
Age 6238 reports
Age 6938 reports
Age 6036 reports
Age 6133 reports
Age 5826 reports
Age 5926 reports
Age 6626 reports
Age 7926 reports
Age 6325 reports
Age 6425 reports
Age 6525 reports
Age 7324 reports
Age 3123 reports
Age 6822 reports
Age 7121 reports
Age 7721 reports
Age 6720 reports
Age 4218 reports
Age 5018 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ADENOSINE?

This profile reflects 3,219 FDA FAERS reports that mention ADENOSINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ADENOSINE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, SUPRAVENTRICULAR TACHYCARDIA, HYPOTENSION, CARDIAC ARREST, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ADENOSINE?

Labeling and FAERS entries often list Dalim Tissen in connection with ADENOSINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.